Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
Wellcome Open Research · 02.11.2023 · 8 · 96
DOI: 10.12688/wellcomeopenres.17995.2 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Wellcome Open Research, online erschienen am 02.11.2023. Verfasst von Samuel Clifford und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UK Medical Research Council, National Institute for Health Research Health Protection Research Unit.
Abstract (Originalsprache)
Background
The ability of SARS-CoV-2 vaccines to protect against infection and onward transmission determines whether immunisation can control global circulation. We estimated the effectiveness of Pfizer-BioNTech mRNA vaccine (BNT162b2) and Oxford AstraZeneca adenovirus vector vaccine (ChAdOx1) vaccines against acquisition and transmission of the Alpha and Delta variants in a prospective household study in England.
Methods
Households were recruited based on adult purported index cases testing positive after reverse transcription-quantitative (RT-q)PCR testing of oral-nasal swabs. Purported index cases and their household contacts took oral-nasal swabs on days 1, 3 and 7 after enrolment and a subset of the PCR-positive swabs underwent genomic sequencing conducted on a subset. We used Bayesian logistic regression to infer vaccine effectiveness against acquisition and transmission, adjusted for age, vaccination history and variant.
Results
Between 2 February 2021 and 10 September 2021, 213 index cases and 312 contacts were followed up. After excluding households lacking genomic proximity (N=2) or with unlikely serial intervals (N=16), 195 households with 278 contacts remained, of whom 113 (41%) became PCR positive. Delta lineages had 1.53 times the risk (95% Credible Interval: 1.04 – 2.20) of transmission than Alpha; contacts older than 18 years old were 1.48 (1.20 – 1.91) and 1.02 (0.93 – 1.16) times more likely to acquire an Alpha or Delta infection than children. Effectiveness of two doses of BNT162b2 against transmission of Delta was 36% (-1%, 66%) and 49% (18%, 73%) for ChAdOx1, similar to their effectiveness for Alpha. Protection against infection with Alpha was higher than for Delta, 69% (9%, 95%) vs. 18% (-11%, 59%), respectively, for BNT162b2 and 24% (-41%, 72%) vs. 9% (-15%, 42%), respectively, for ChAdOx1.
Conclusions
BNT162b2 and ChAdOx1 reduce transmission of the Delta variant from breakthrough infections in the household setting, although their protection against infection within this setting is low.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.
- Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.
- National Infection Service, UK Health Security Agency, London, NW9 5EQ, UK.
ORCID-Profile: Samuel Clifford, Jada Hackman, Stefan Flasche
Förderung
- Wellcome Trust
- UK Medical Research Council
- National Institute for Health Research Health Protection Research Unit
- Nagasaki University-London School of Hygiene & Tropical Medicine Doctoral Programme
- UK Health Security Agency
Zitieren
APA
Clifford, S., Waight, P., Hackman, J., Hué, S., Gower, C. M., Kirsebom, F. C., Skarnes, C., Letley, L., Lopez Bernal, J., Andrews, N., Flasche, S., & Miller, E. (2023). Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England. Wellcome Open Research, 8, 96. https://doi.org/10.12688/wellcomeopenres.17995.2
Vancouver
Clifford S, Waight P, Hackman J, Hué S, Gower CM, Kirsebom FC, et al. Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England. Wellcome Open Research. 2023;8:96. doi:10.12688/wellcomeopenres.17995.2
BibTeX
@article{Clifford2023,
author = {Clifford, Samuel and Waight, Pauline and Hackman, Jada and Hué, Stephane and Gower, Charlotte M and Kirsebom, Freja Cm and Skarnes, Catriona and Letley, Louise and Lopez Bernal, Jamie and Andrews, Nick and Flasche, Stefan and Miller, Elizabeth},
title = {Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England},
journal = {Wellcome Open Research},
year = {2023},
volume = {8},
pages = {96},
doi = {10.12688/wellcomeopenres.17995.2}
}
EUVIMED